These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29407951)
1. Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α). Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V Eur J Med Chem; 2018 Feb; 146():206-219. PubMed ID: 29407951 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators. Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha. Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazoles. Karadayi FZ; Yaman M; Kisla MM; Keskus AG; Konu O; Ates-Alagoz Z Bioorg Chem; 2020 Jul; 100():103929. PubMed ID: 32464404 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel indole based heterocycles as selective estrogen receptor modulator. Singla R; Prakash K; Bihari Gupta K; Upadhyay S; Dhiman M; Jaitak V Bioorg Chem; 2018 Sep; 79():72-88. PubMed ID: 29723744 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents. Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819 [TBL] [Abstract][Full Text] [Related]
7. Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-α inhibition. Hendy MS; Ali AA; Ahmed L; Hossam R; Mostafa A; Elmazar MM; Naguib BH; Attia YM; Ahmed MS Eur J Med Chem; 2019 Mar; 166():281-290. PubMed ID: 30731397 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, and Choudhari RC; Kaur K; Das A; Jaitak V Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813 [TBL] [Abstract][Full Text] [Related]
11. Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity. Ragab MA; Elagawany M; Daabees H; Ahmed AF; Awad EM; Billon C; Elgendy B; Abouzid KAM; Kassab SE Bioorg Chem; 2022 Feb; 119():105554. PubMed ID: 34923243 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents. Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo[3,2-a]benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation. Al-Ansary GH; Eldehna WM; Ghabbour HA; Al-Rashood STA; Al-Rashood KA; Eladwy RA; Al-Dhfyan A; Kabil MM; Abdel-Aziz HA J Enzyme Inhib Med Chem; 2017 Dec; 32(1):986-991. PubMed ID: 28726519 [TBL] [Abstract][Full Text] [Related]
15. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells. Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities. Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer. Bai C; Ren S; Wu S; Zhu M; Luo G; Xiang H Eur J Med Chem; 2021 Oct; 221():113543. PubMed ID: 34022716 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents. El-Gohary NS; Shaaban MI Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Abdelgawad MA; Bakr RB; Omar HA Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]